Celldex Therapeutics, Inc. — Director's Dealing 2024

Jun 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2024-06-05

Reporting Person: Jimenez Freddy A. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-05	Common Stock	M	9540	$10.38	Acquired	35464	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-05	Incentive Stock Option (Right to Buy)	$10.38	M	9540	Disposed	2030-06-18	Common Stock (9540)	Direct

Footnotes

F1: 25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.